Ceritinib Interactions
There are 734 drugs known to interact with ceritinib, along with 8 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 401 are major, 320 are moderate, and 13 are minor.
- View all 734 medications that may interact with ceritinib
- View ceritinib alcohol/food interactions (2)
- View ceritinib disease interactions (8)
Most frequently checked interactions
View interaction reports for ceritinib and the medicines listed below.
- Activated Charcoal (charcoal)
- Aspirin Low Strength (aspirin)
- Ativan (lorazepam)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Coenzyme Q10 (ubiquinone)
- Copper (copper gluconate)
- Dextrose (glucose)
- Diltiazem Hydrochloride SR (diltiazem)
- Ecoza (econazole topical)
- Ethyl Alcohol (ethanol)
- Farxiga (dapagliflozin)
- Glycerol (glycerin)
- Heparin Sodium (heparin)
- Humalog KwikPen (insulin lispro)
- Iodides (sodium iodide)
- Iron Sulfate (ferrous sulfate)
- Jardiance (empagliflozin)
- Keppra (levetiracetam)
- L-Arginine (arginine)
- L-Carnitine (levocarnitine)
- L-Cysteine (cysteine)
- Lantus SoloStar (insulin glargine)
- Lithium Carbonate ER (lithium)
- Metamucil Orange Smooth Texture Sugar Free (psyllium)
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Tartrate (metoprolol)
- Paracetamol (acetaminophen)
- Paracetamol Zydus (acetaminophen)
- Quercetin (bioflavonoids)
- Vitamin B12 (cyanocobalamin)
Ceritinib alcohol/food interactions
There are 2 alcohol/food interactions with ceritinib.
Ceritinib disease interactions
There are 8 disease interactions with ceritinib which include:
- QT prolongation
- bradycardia
- GI complications
- hepatic impairment
- hyperglycemia
- pancreatitis
- renal impairment
- lung toxicity
Report options
More about ceritinib
- ceritinib consumer information
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Rybrevant
Rybrevant is used to treat advanced non-small cell lung cancer (NSCLC) in adults that has certain ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Avastin
Avastin is used to brain tumors and cancers of the kidney, colon, rectum, or lung. Learn about side ...
Tagrisso
Tagrisso (osimertinib) may be used to treat adults with non-small cell lung cancer (NSCLC) whose ...
Gemcitabine
Gemcitabine is used for breast cancer, breast cancer, metastatic, nasopharyngeal carcinoma, non ...
Nivolumab
Nivolumab is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Paclitaxel
Paclitaxel is used for breast cancer, breast cancer, adjuvant, breast cancer, metastatic, kaposi's ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
